PTC Therapeutics
PTCT
#3037
Rank
HK$41.55 B
Marketcap
HK$497.93
Share price
-1.04%
Change (1 day)
-2.10%
Change (1 year)

Market capitalization of PTC Therapeutics (PTCT)

Market cap: HK$41.55 Billion

As of October 2026 PTC Therapeutics has a market cap of HK$41.55 Billion. This makes PTC Therapeutics the world's 3037th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of PTC Therapeutics from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$41.55 B-15.32%
2025HK$49.07 B81.21%
2024HK$27.08 B66.73%
2023HK$16.24 B-25.37%
2022HK$21.76 B-0.88%
2021HK$21.95 B-31.99%
2020HK$32.28 B39.35%
2019HK$23.16 B70.34%
2018HK$13.60 B151.54%
2017HK$5.40 B86.23%
2016HK$2.90 B-65.91%
2015HK$8.51 B-35.53%
2014HK$13.21 B321.75%
2013HK$3.13 B

End of Day market cap according to different sources

On Oct 3rd, 2026 the market cap of PTC Therapeutics was reported to be:

HK$41.55 Billion
by Nasdaq info icon info icon
HK$41.55 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Novartis
NVS
HK$2.102 T 4,960.03%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vertex Pharmaceuticals
VRTX
HK$1.003 T 2,313.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
HK$14.49 B-65.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
HK$14.50 B-65.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
HK$2.18 B-94.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
HK$88.26 B 112.39%๐Ÿ‡บ๐Ÿ‡ธ USA